Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative effect adjustment for ASC 842 lease accounting adoption
Private Placement
Note Warrant
Parent
Parent
Cumulative effect adjustment for ASC 842 lease accounting adoption
Parent
Private Placement
Parent
Note Warrant
Preferred Stock Issued
Common Stock Issued
Common Stock Issued
Private Placement
Common Stock Issued
Note Warrant
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Note Warrant
Accumulated Deficit
Accumulated Deficit
Cumulative effect adjustment for ASC 842 lease accounting adoption
Noncontrolling interest
Beginning balance (in shares) at Aug. 31, 2020                 0 16,902,146                
Beginning balance at Aug. 31, 2020         $ (30)       $ 0 $ 2     $ 119,430     $ (119,462)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                     4,000,000              
Common stock issued, net of offering costs             $ 10,701             $ 10,701        
Stock-based compensation expense         863               863          
Preferred stock issued for preferred option exercised (in shares)                 12,500                  
Common stock issued on preferred stock conversion (in shares)                 (12,500) 12,500                
Net Loss $ (13,119)       (13,119)                     (13,119)    
Ending balance (in shares) at Feb. 28, 2021                 0 20,914,646                
Ending balance at Feb. 28, 2021         (1,585)       $ 0 $ 2     130,994     (132,581)    
Beginning balance (in shares) at Aug. 31, 2020                 0 16,902,146                
Beginning balance at Aug. 31, 2020         (30)       $ 0 $ 2     119,430     (119,462)    
Ending balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Ending balance at Aug. 31, 2021 $ 40,923 $ 608     (6,549) $ 608     $ 0 $ 3     142,786     (149,338) $ 608 $ 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2018-11                                  
Beginning balance (in shares) at Nov. 30, 2020                 0 20,902,146                
Beginning balance at Nov. 30, 2020         4,156       $ 0 $ 2     130,552     (126,398)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense         442               442          
Preferred stock issued for preferred option exercised (in shares)                 12,500                  
Common stock issued on preferred stock conversion (in shares)                 (12,500) 12,500                
Net Loss $ (6,183)       (6,183)                     (6,183)    
Ending balance (in shares) at Feb. 28, 2021                 0 20,914,646                
Ending balance at Feb. 28, 2021         (1,585)       $ 0 $ 2     130,994     (132,581)    
Beginning balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Beginning balance at Aug. 31, 2021 40,923 608     (6,549) 608     $ 0 $ 3     142,786     (149,338) 608 47,472
Ending balance (in shares) at Nov. 30, 2021                 0 28,713,099                
Ending balance at Nov. 30, 2021 $ 30,392 608     (17,080) 608     $ 0 $ 3     140,968     (158,051) 608 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2018-11                                  
Beginning balance (in shares) at Aug. 31, 2021                 0 25,863,099                
Beginning balance at Aug. 31, 2021 $ 40,923 608     (6,549) 608     $ 0 $ 3     142,786     (149,338) 608 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                     2,850,000 4,948,453            
Common stock issued, net of offering costs     $ 4,183 $ 5,409     $ 4,183 $ 5,409           $ 4,183 $ 5,409      
Prefunded warrants from private placement, net of offering costs 6,861       6,861               6,861          
Stock-based compensation expense 747       747               747          
Excess of proceeds from the sale of private placement warrants to Sponsor (13,270)       (13,270)               (13,270)          
Withdrawal of SPAC registrations under Form S-1 (37,978)                                 (37,978)
Net Loss (18,210)       (18,210)                     (18,210)    
Ending balance (in shares) at Feb. 28, 2022                 0 33,661,552                
Ending balance at Feb. 28, 2022 (10,727)       (20,221)       $ 0 $ 3     146,716     (166,940)   9,494
Beginning balance (in shares) at Nov. 30, 2021                 0 28,713,099                
Beginning balance at Nov. 30, 2021 30,392 $ 608     (17,080) $ 608     $ 0 $ 3     140,968     (158,051) $ 608 47,472
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Common stock issued, net of offering costs (in shares)                       4,948,453            
Common stock issued, net of offering costs       $ 5,409       $ 5,409             $ 5,409      
Stock-based compensation expense 339       339               339          
Withdrawal of SPAC registrations under Form S-1 (37,978)                                 (37,978)
Net Loss (9,497)       (9,497)                     (9,497)    
Ending balance (in shares) at Feb. 28, 2022                 0 33,661,552                
Ending balance at Feb. 28, 2022 $ (10,727)       $ (20,221)       $ 0 $ 3     $ 146,716     $ (166,940)   $ 9,494